User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course

Primary tabs

Put, Natalie Van Roosbroeck, Katrien Konings, Peter Meeus, Peter Brusselmans, Caroline Poirel, Hélène [UCL] Michaux, Lucienne [UCL]

Translocations involving MYC are rare in chronic lymphocytic leukemia (CLL), and up to now, their prognostic significance remains unclear. We report the characteristics of 21 patients with CLL and nine patients with prolymphocytic leukemia (PLL), diagnosed in multiple centers (n = 13), which showed an MYC translocation demonstrated by fluorescence in situ hybridization. The prevalence was estimated to be <1%. Advanced age and male predominance were observed. Morphological analysis frequently revealed the presence of prolymphocytes. A typical "CLL-immunophenotype" was found in four of nine cases with PLL. Moreover, CD5 and CD23 were frequently expressed in PLL. The latter findings are atypical for PLL and may suggest transformation or progression of an underlying CLL. MYC translocations were frequently observed with concomitant adverse cytogenetic markers, such as del(11q) (n = 8/30) and/or del(17p)/monosomy 17 (n = 7/30). In addition, the presence of unbalanced translocations (n = 24 in 13/30 cases) and complex karyotype (n = 16/30) were frequent in cases with MYC translocations. Altogether, del(17p)/monosomy 17, del(11q), and/or complex karyotype were observed in 22 of 30 patients. Survival outcome was poor: the median time to treatment was only 5 months, and overall survival (OS) from clinical diagnosis and from genetic detection was 71 and 19 months, respectively. In conclusion, CLL/PLL with MYC translocations is a rare entity, which seems to be associated with adverse prognostic features and unfavorable outcome.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2012
Language Anglais
Journal information "Annals of Hematology" - Vol. 91, no.6, p. 863-873 (2011)
Peer reviewed yes
Publisher Springer ((Germany) Heidelberg)
issn 0939-5555
e-issn 1432-0584
Publication status Publié
Affiliations UCL - SSS/DDUV - Institut de Duve
UCL - SSS/IREC - Institut de recherche expérimentale et clinique
UCL - (SLuc) Service d'hématologie
UCL - (SLuc) Centre de génétique médicale UCL
MESH Subject Aged ; Female ; Genes, myc ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell ; Leukemia, Prolymphocytic ; Male ; Middle Aged ; Neoplasm Invasiveness ; Retrospective Studies ; Translocation, Genetic ; Aged, 80 and over ; Case-Control Studies ; Chromosomes, Human, Pair 14 ; Chromosomes, Human, Pair 2 ; Chromosomes, Human, Pair 22 ; Chromosomes, Human, Pair 8 ; Cohort Studies ; Disease Progression
Links
  1. Binet J.-L., Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia, 10.1182/blood-2005-04-1677
  2. Van Den Neste E, Robin V, Francart J, Hagemeijer A, Stul M, Vandenberghe P, Delannoy A, Sonet A, Deneys V, Costantini S, Ferrant A, Robert A, Michaux L, Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine, 10.1038/sj.leu.2404764
  3. Dicker F., Schnittger S., Haferlach T., Kern W., Schoch C., Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: a study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression, 10.1182/blood-2006-02-005322
  4. Mayr C., Chromosomal translocations are associated with poor prognosis in chronic lymphocytic leukemia, 10.1182/blood-2005-05-2093
  5. Barrans Sharon, Crouch Simon, Smith Alex, Turner Kathryn, Owen Roger, Patmore Russell, Roman Eve, Jack Andrew, Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab, 10.1200/jco.2009.26.3947
  6. Avet-Loiseau H., Attal M., Moreau P., Charbonnel C., Garban F., Hulin C., Leyvraz S., Michallet M., Yakoub-Agha I., Garderet L., Marit G., Michaux L., Voillat L., Renaud M., Grosbois B., Guillerm G., Benboubker L., Monconduit M., Thieblemont C., Casassus P., Caillot D., Stoppa A.-M., Sotto J.-J., Wetterwald M., Dumontet C., Fuzibet J.-G., Azais I., Dorvaux V., Zandecki M., Bataille R., Minvielle S., Harousseau J.-L., Facon T., Mathiot C., Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome, 10.1182/blood-2006-08-040410
  7. Obermann E C, Csato M, Dirnhofer S, Tzankov A, Aberrations of the MYC gene in unselected cases of diffuse large B-cell lymphoma are rare and unpredictable by morphological or immunohistochemical assessment, 10.1136/jcp.2009.065227
  8. Huh Yang O., Lin Katherine I-Chun, Vega Francisco, Schlette Ellen, Yin C. Cameron, Keating Michael J., Luthra R., Medeiros L. Jeffrey, Abruzzo Lynne V., MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis, 10.1111/j.1365-2141.2008.07152.x
  9. Mitelman F, Johansson B, Mertens F (eds) (2010) Mitelman database of chromosome aberrations and gene fusions in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman
  10. Klapproth Kay, Wirth Thomas, Advances in the understanding of MYC-induced lymphomagenesis : Review, 10.1111/j.1365-2141.2010.08159.x
  11. Bertrand P, Bastard C, Maingonnat C, Jardin F, Maisonneuve C, Courel M-N, Ruminy P, Picquenot J-M, Tilly H, Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas, 10.1038/sj.leu.2404529
  12. Nowakowski G. S., Dewald G. W., Hoyer J. D., Paternoster S. F., Stockero K. J., Fink S. R., Smoley S. A., Remstein E. D., Phyliky R. L., Call T. G., Shanafelt T. D., Kay N. E., Zent C. S., Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia, 10.1111/j.1365-2141.2005.05548.x
  13. Cavazzini Francesco, Hernandez Jose Angel, Gozzetti Alessandro, Russo Rossi Antonella, De Angeli Cristiano, Tiseo Ruana, Bardi Antonella, Tammiso Elisa, Crupi Rosaria, Lenoci Maria Pia, Forconi Francesco, Lauria Francesco, Marasca Roberto, Maffei Rossana, Torelli Giuseppe, Gonzalez Marcos, Martin-Jimenez Patricia, Maria Hernandez Jesus, Rigolin Gian Matteo, Cuneo Antonio, Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis : Poor Prognosis in CLL with 14q32 Translocation, 10.1111/j.1365-2141.2008.07227.x
  14. Bennett J M, Catovsky D, Daniel M T, Flandrin G, Galton D A, Gralnick H R, Sultan C, Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group., 10.1136/jcp.42.6.567
  15. Matutes E, Owusu-Ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, Catovsky D (1994) The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 8:1640–1645
  16. Moreau Elisabeth J., Matutes Estella, A’Hern Roger P., Morilla Alison M., Morilla Ricardo M., Owusu-Ankomah Kwasi A., Seon Ben K., Catovsky Daniel, Improvement of the Chronic Lymphocytic Leukemia Scoring System With the Monoclonal Antibody SN8(CD79b), 10.1093/ajcp/108.4.378
  17. Put Natalie, Konings Peter, Rack Katrina, Jamar Mauricette, Roy Nadine Van, Libouton Jeanne-Marie, Vannuffel Pascal, Sartenaer Daniel, Ameye Geneviève, Speleman Frank, Herens Christian, Poirel Hélène A., Moreau Yves, Hagemeijer Anne, Vandenberghe Peter, Michaux Lucienne, , Improved detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide and interleukin-2 stimulation: A Belgian multicentric study, 10.1002/gcc.20691
  18. Brochet X., Lefranc M.-P., Giudicelli V., IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis, 10.1093/nar/gkn316
  19. Henglein B, Synovzik H, Groitl P, Bornkamm G W, Hartl P, Lipp M, Three breakpoints of variant t(2;8) translocations in Burkitt's lymphoma cells fall within a region 140 kilobases distal from c-myc., 10.1128/mcb.9.5.2105
  20. R Development Core Team (2010) R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna
  21. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O’Brien S, Rai KR (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87:4990–4997
  22. Hallek M., Cheson B. D., Catovsky D., Caligaris-Cappio F., Dighiero G., Dohner H., Hillmen P., Keating M. J., Montserrat E., Rai K. R., Kipps T. J., Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines, 10.1182/blood-2007-06-093906
  23. Juliusson Gunnar, Oscier David G., Fitchett Margaret, Ross Fiona M., Stockdill George, Mackie Michael J., Parker Alistair C., Castoldi Gian Luigi, Cuneo Antonio, Knuutila Sakari, Elonen Erkki, Gahrton Gösta, Prognostic Subgroups in B-Cell Chronic Lymphocytic Leukemia Defined by Specific Chromosomal Abnormalities, 10.1056/nejm199009133231105
  24. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T, Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping, 10.1038/sj.leu.2404935
  25. Nowakowski GS, Smoley S, Schwager S, Zent CS, Call TG, Shanafelt TD, Hanson CA, Tschumper RC, Jelinek DF, Van Dyke DL, Kay NE (2007) Presence of immunoglobulin heavy chain gene (IGH) translocations in chronic lymphocytic leukemia is related to poor prognosis. ASH Annual Meeting Abstracts, vol 110, p. 2067
  26. Martín-Subero J I, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, Calasanz M J, De Wolf-Peeters C, Dyer M J, Felman P, Gardiner A, Gascoyne R D, Gesk S, Harder L, Horsman D E, Kneba M, Küppers R, Majid A, Parry-Jones N, Ritgen M, Salido M, Solé F, Thiel G, Wacker H-H, Oscier D, Wlodarska I, Siebert R, A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation, 10.1038/sj.leu.2404695
  27. Chapiro E, Radford-Weiss I, Bastard C, Luquet I, Lefebvre C, Callet-Bauchu E, Leroux D, Talmant P, Mozziconacci M-J, Mugneret F, Struski S, Raynaud S, Andrieux J, Barin C, Jotterand M, Mossafa H, Ramond S, Terré C, Lippert E, Berger F, Felman P, Merle-Béral H, Bernard O A, Davi F, Berger R, Nguyen-Khac F, The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia, 10.1038/leu.2008.102
  28. Put N, Meeus P, Chatelain B, Rack K, Boeckx N, Nollet F, Graux C, Van Den Neste E, Janssens A, Madoe V, Van Hoof A, Bilhou-Nabera C, Wlodarska I, Vandenberghe P, Michaux L, Translocation t(14;18) is not associated with inferior outcome in chronic lymphocytic leukemia, 10.1038/leu.2009.44
  29. Delgado M. D., Leon J., Myc Roles in Hematopoiesis and Leukemia, 10.1177/1947601910377495
  30. Zhang W., Kater A. P., Widhopf G. F., Chuang H.-Y., Enzler T., James D. F., Poustovoitov M., Tseng P.-H., Janz S., Hoh C., Herschman H., Karin M., Kipps T. J., B-cell activating factor and v-Myc myelocytomatosis viral oncogene homolog (c-Myc) influence progression of chronic lymphocytic leukemia, 10.1073/pnas.1013420107
  31. REDAELLI A., LASKIN B.L., STEPHENS J.M., BOTTEMAN M.F., PASHOS C.L., The clinical and epidemiological burden of chronic lymphocytic leukaemia, 10.1111/j.1365-2354.2004.00489.x
  32. Merchant S, Schlette E, Sanger W, Lai R, Medeiros LJ (2003) Mature B-cell leukemias with more than 55% prolymphocytes: report of 2 cases with Burkitt lymphoma-type chromosomal translocations involving c-myc. Arch Pathol Lab Med 127:305–309
  33. Kroft Steven H., Dawson D. Brian, McKenna Robert W., Large Cell Lymphoma Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma : A Flow Cytometric Analysis of Seven Cases, 10.1309/f5we-k2t8-bt9d-q56d
  34. Döhner Hartmut, Stilgenbauer Stephan, Benner Axel, Leupolt Elke, Kröber Alexander, Bullinger Lars, Döhner Konstanze, Bentz Martin, Lichter Peter, Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia, 10.1056/nejm200012283432602
  35. Lau Lai-Ching, Lim Ping, Lim Yik-Chen, Teng Li-Min, Lim Tse-Hui, Lim Lay–Cheng, Tan Soo-Yong, Lim Soon-Tiong, Sanger Warren G., Tien Sim-Leng, Occurrence of trisomy 12, t(14;18)(q32;q21), and t(8;14)(q24.1;q11.2) in a patient with B-cell chronic lymphocytic leukemia, 10.1016/j.cancergencyto.2008.04.017
  36. Lens D, Coignet LJA, Brito-Babapulle V, Lima CSP, Matutes E, Dyer MJS, Catovsky D, B cell prolymphocytic leukaemia (B-PLL) with complex karyotype and concurrent abnormalities of the p53 and c-MYC gene, 10.1038/sj.leu.2401416
  37. Maclean K. H., Kastan M. B., Cleveland J. L., Atm Deficiency Affects Both Apoptosis and Proliferation to Augment Myc-Induced Lymphomagenesis, 10.1158/1541-7786.mcr-07-0058
  38. Eischen C. M., Weber J. D., Roussel M. F., Sherr C. J., Cleveland J. L., Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis, 10.1101/gad.13.20.2658
Bibliographic reference Put, Natalie ; Van Roosbroeck, Katrien ; Konings, Peter ; Meeus, Peter ; Brusselmans, Caroline ; et. al. Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course. In: Annals of Hematology, Vol. 91, no.6, p. 863-873 (2011)
Permanent URL http://hdl.handle.net/2078.1/158121